Clinical Trials Search

Title Intervention Sponsor Sort descending Status
Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced Cancer Adaptation of IMCP for Chinese Immigrant Cancer Patients, In-depth Patient Interviews, Individual Meaning-Centered Psychotherapy for Chinese (IMCP-Ch) (For Phase 3 and Phase 4) Memorial Sloan Kettering Cancer Center Recruiting
CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts Paclitaxel + Gemcitabine admixture, Ethanol, Normal saline Milton S. Hershey Medical Center Recruiting
Prevention of Oral DNA Damage by Black Raspberries BRB Lozenges Milton S. Hershey Medical Center Recruiting
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion Laboratory Biomarker Analysis, Metformin Hydrochloride National Cancer Institute (NCI) Active, not recruiting
NCI COVID-19 in Cancer Patients, NCCAPS Study Biospecimen Collection, Data Collection, Quality-of-Life Assessment, Questionnaire Administration National Cancer Institute (NCI) Active, not recruiting
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis Questionnaire Administration, Simvastatin, Placebo Administration, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging National Cancer Institute (NCI) Active, not recruiting
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia Curcumin, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Placebo Administration National Cancer Institute (NCI) Active, not recruiting
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid National Cancer Institute (NCI) Active, not recruiting
GCC Agonist Signal in the Small Intestine Biopsy, Biospecimen Collection, Esophagogastroduodenoscopy, Linaclotide, Plecanatide National Cancer Institute (NCI) Recruiting
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine National Cancer Institute (NCI) Active, not recruiting